Newsfeeds - Spark Newswire

3 minute read

Opiant Pharmaceuticals Announces CFIUS Approval For Proposed Acquisition By Indivior PLC; Under The Terms Of The Agreement, Indivior Will Acquire All The Outstanding Shares Of Opiant For Upfront Consideration Of $20.00 Per Share In Cash At Closing

Today, 10:53 AM

CFIUS clearance represents the final required regulatory approval to complete the proposed merger Completion remains subject to the approval of Opiant stockholders; a special stockholder meeting to approve

OPNT

2 minute read

M&A
News

Opiant Pharmaceuticals Announces Expiration Of Hart-Scott-Rodino Waiting Period For Proposed Acquisition By Indivior PLC

By Happy Mohamed

Today, 10:53 AM

Opiant Pharmaceuticals Inc. (NASDAQ:OPNT) announced today the expiration of the waiting period under the United States (U.S.) Hart-Scott-Rodino Act of 1976, as amended (HSR Act), with respect to the previously announced

OPNT

1 minute read

U.S. Senator Elizabeth Warren Writes FTC To Express Concern About Two Pharmaceutical Deals; Warren Tells Agency She Is “Particularly Concerned” About Amgen Plan To Buy Horizon Therapeutics And Indivior’s Plan To Buy Opiant Pharmaceuticals

By Benzinga Newsdesk

Today, 10:53 AM

- Reuters

AMGN

2 minute read

Tesla, Amazon, Opiant, Nu, Paramount: Lawsuit, Earnings, Warren Buffett’s Increased Stake Draw Investor Attention

By Bhavik Nair

Today, 10:53 AM

Major Wall Street indices closed in the red on Monday, in a reversal of last week’s rally driven by softer inflation data.

AMZN

3 minute read

Dow Surges 150 Points; Crude Oil Falls Sharply

By Lisa Levin

Today, 10:53 AM

U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones gaining around 150 points on Monday.

FRGT

4 minute read

Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

Today, 10:53 AM

Gainers Freight Technologies, Inc. (NASDAQ: FRGT) shares surged 137% to $0.4901 after analysts at Chardan Capital initiated coverage of the stock with a $2.25 price target.

AGEN

3 minute read

US Stocks Mostly Lower; Nasdaq Drops Over 100 Points

By Lisa Levin

Today, 10:53 AM

U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping more than 100 points on Monday.

ARDX

5 minute read

Facebook Stalls Portal & Smartwatch Projects, Visa Breaks Debit Card Tie Up With FTX, $3B Bitcoin Withdrawn From Crypto Exchanges: Top Stories Monday, Nov. 14

By Vandana Singh

Today, 10:53 AM

Reuters

BABA

17 minute read

Earnings

Earnings Scheduled For November 14, 2022

By Benzinga Insights

Today, 10:53 AM

Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.

AAIC

2 minute read

M&A
News

Indivior PLC to Acquire Opiant Pharmaceuticals for $20/Share in Cash Plus CVR Worth Up to $8/Share

By Charles Gross

Today, 10:53 AM

Opiant Pharmaceuticals Inc. (NASDAQ: OPNT) today announced that it has entered into a definitive merger agreement to be acquired by Indivior Inc, a subsidiary of Indivior PLC (LON: INDV).

OPNT